In recent years, considerable progress has been made in understanding the biology of canine lymphoma with resultant enhanced classification schemes and the possibility of individualised, tailored therapies. However, although complete remission may be achieved using multi-agent chemotherapy, the mortality rate from this neoplasm remains high. This review focuses on the staging of high-grade multicentric lymphoma in the dog, on conventional and novel treatment strategies (including chemotherapy, bone marrow transplantation, radiation therapy and molecular-targeted agents), and on the management of relapsed or refractory cases. (C) 2010 Elsevier Ltd. All rights reserved.
The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects / Marconato L.. - In: THE VETERINARY JOURNAL. - ISSN 1090-0233. - ELETTRONICO. - 188:1(2011), pp. 34-38. [10.1016/j.tvjl.2010.04.027]
The staging and treatment of multicentric high-grade lymphoma in dogs: A review of recent developments and future prospects
Marconato L.
2011
Abstract
In recent years, considerable progress has been made in understanding the biology of canine lymphoma with resultant enhanced classification schemes and the possibility of individualised, tailored therapies. However, although complete remission may be achieved using multi-agent chemotherapy, the mortality rate from this neoplasm remains high. This review focuses on the staging of high-grade multicentric lymphoma in the dog, on conventional and novel treatment strategies (including chemotherapy, bone marrow transplantation, radiation therapy and molecular-targeted agents), and on the management of relapsed or refractory cases. (C) 2010 Elsevier Ltd. All rights reserved.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
